Detalhe da pesquisa
1.
A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor.
Diabetes Obes Metab
; 26(2): 592-601, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953687